Briefcases -- Drugs -- INVOKANA (canagliflozin) MDL 2750 USDC New Jersey

INVOKANA (canagliflozin) MDL 2750 USDC New Jersey

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. JPML Initial Transfer and Consolidation Order
  2. Initial Case Filing Templates
    1. Plaintiff Fact Sheet(s)
    2. Defendant Fact Sheet(s)
  3. Court Orders
    1. Case Management Orders (CMOs)
    2. Leadership Committee and Appointments
    3. Discovery and Protective Orders
  4. Bellwether Cases
    1. Selections
  5. Evidentiary and Research Documents
    1. FDA Regulatory Materials

Quick Access

  1. INVOKANA MDL 2750 CMO No. 2 Plaintiffs' Steering Committee and Leadership Appointments (January 24, 2017)
  2. INVOKANA MDL 2750 CMO No. 4 Direct Filing Order (March 10, 2017)
  3. INVOKANA MDL 2750 CMO No. 18 (TEMPLATES) Plaintiff and Defendant Fact Sheets with HIPAA (June 16, 2017)
  4. INVOKANA MDL 2750 Court Appointed Plaintiffs' Steering Committee List per CMO No. 2
  5. INVOKANA MDL 2750 CMO No. 17 Protective Order
  6. INVOKANA MDL 2750 CMO No. 2 Plaintiffs' Steering Committee and Leadership Appointments (January 24, 2017)
  7. INVOKANA MDL 2750 Plaintiffs' Motion to JPML for Transfer and Coordination (September 20, 2016)
  8. INVOKANA MDL 2750 CMO No. 18 (TEMPLATES) Plaintiff and Defendant Fact Sheets (June 16, 2017)